Reprogramming the Host Response in Bacterial Meningitis: How Best To Improve Outcome?

AUTOR(ES)

van der Flier, M.

FONTE

American Society for Microbiology

RESUMO

Despite effective antibiotic therapy, bacterial meningitis is still associated with high morbidity and mortality in both children and adults. Animal studies have shown that the host inflammatory response induced by bacterial products in the subarachnoid space is associated with central nervous system injury. Thus, attenuation of inflammation early in the disease process might improve the outcome. The feasibility of such an approach is demonstrated by the reduction in neurologic sequelae achieved with adjuvant dexamethasone therapy. Increased understanding of the pathways of inflammation and neuronal damage has suggested rational new targets to modulate the host response in bacterial meningitis, but prediction of which agents would be optimal has been difficult. This review compares the future promise of benefit from the use of diverse adjuvant agents. It appears unlikely that inhibition of a single proinflammatory mediator will prove useful in clinical practice, but several avenues to reprogram a wider array of mediators simultaneously are encouraging. Particularly promising are efforts to adjust combinations of cytokines, to inhibit neuronal apoptosis and to enhance brain repair.

Documentos Relacionados

• Does administering albumin to postoperative gastroschisis patients improve outcome?
• Dexamethasone treatment for acute bacterial meningitis: how strong is the evidence for routine use?
• Dexamethasone treatment for acute bacterial meningitis: how strong is the evidence for routine use?
• Prognostic indicators in bacterial meningitis: a case-control study
• Do Kinetics of the Humoral Response to Cryptococcus neoformans Proteins during Murine Cryptococcosis Reflect Outcome?